Science in Sport (SIS) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
6 Jun, 2025Financial performance highlights
FY24 revenue reached £62.8m, up 17.5% from FY23, with H2 growth of 1.9% over H1.
Adjusted EBITDA doubled to £4.2m in FY24, a 105% increase from £2.0m in FY23.
Net debt reduced significantly to £5.9m from £12.9m, reflecting improved cash generation.
Gross margins improved to over 45% in FY24, up from 43% in FY23.
Operational improvements and cost base reductions under new leadership drove profitability.
Strategic and operational updates
Reset of the operating model and cost savings initiatives are underpinning performance gains.
Distribution agreements and omnichannel sales are supporting domestic and international growth.
Focus remains on disciplined pricing, operational change, and marketing execution.
Management is confident in achieving a 15% EBITDA margin earlier than previously anticipated.
Continued deleveraging and reinvestment for growth are strategic priorities.
Brand and market positioning
Operates two leading brands: PhD Nutrition (active lifestyle) and SiS (endurance nutrition).
Products sold via digital platforms, third-party sites, and extensive retail distribution.
SiS supplies over 320 professional teams and 150 football clubs globally.
PhD Nutrition recognized for high quality and innovation, with a broad product range.
Omnichannel approach enables broad market reach in sports nutrition.
Latest events from Science in Sport
- Margin-led turnaround delivers higher EBITDA despite lower sales, with strong liquidity for growth.SIS
H1 202413 Jun 2025 - EBITDA surged 77% as Science in Sport prioritised margin and cost efficiency over top-line growth.SIS
Trading Update13 Jun 2025 - Underlying EBITDA turned positive as cost savings and margin gains offset lower revenue.SIS
H2 202313 Jun 2025